Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | REC-2282 |
| Trade Name | |
| Synonyms | AR-42|HDAC42|AR42|AR 42||REC2282|REC 2282 |
| Drug Descriptions |
REC-2282 (AR-42) is a histone deacetylase (HDAC) inhibitor, which may lead to increased apoptosis of tumor cells and decreased tumor growth (PMID: 23178755, PMID: 21778190). |
| DrugClasses | HDAC Inhibitor 45 |
| CAS Registry Number | 935881-37-1 |
| NCIT ID | C116850 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cisplatin + REC-2282 | Cisplatin REC-2282 | 0 | 0 |
| Decitabine + REC-2282 | Decitabine REC-2282 | 0 | 1 |
| Dexamethasone + Pomalidomide + REC-2282 | Dexamethasone Pomalidomide REC-2282 | 0 | 1 |
| Pazopanib + REC-2282 | Pazopanib REC-2282 | 0 | 1 |
| REC-2282 | REC-2282 | 2 | 2 |